Visual Compatibility of Various Injectable Neuroleptic Agents with Benztropine and Lorazepam in Polypropylene Syringes
نویسنده
چکیده
Background: The nursing staff at the authors’ hospital are frequently called upon to administer medications by intramuscular injection during psychiatric emergencies. Many of these medications are considered incompatible when mixed together, and up to 3 separate injections may be required for a single patient. The need for multiple injections increases the risk of needle-stick injury in these situations. Objectives: The visual compatibility of various combinations of haloperidol, loxapine, chlorpromazine, benztropine, and lorazepam was studied, with the aim of reducing the number of injections required and hence reducing the risk to staff and increasing patient comfort. Methods: To emulate the setting of a nursing unit, single syringes of selected combinations of medications were prepared on a clean tabletop under fluorescent light at room temperature. The syringes were visually inspected for haze, immiscibility, precipitation, and colour change at 15, 30, and 45 min and at 1, 2, 3, and 4 h after mixing. Results: The haloperidol–benztropine mixtures and the haloperidol–benztropine–lorazepam mixtures were compatible on visual inspection throughout the observation period. The loxapine–benztropine and loxapine–lorazepam mixtures showed immediate incompatibility, as did the chlorpromazine–lorazepam and benztropine–lorazepam mixtures. A table of compatibilities was produced for quick reference on nursing units. Conclusions: Mixtures of haloperidol and benztropine and of haloperidol, benztropine, and lorazepam are compatible for periods of up to 4 h. The combinations of loxapine and benztropine, loxapine and lorazepam, chlorpromazine and lorazepam, and benztropine and lorazepam should not be mixed before administration.
منابع مشابه
Neuroleptic malignant syndrome following catatonia: Vigilance is the price of antipsychotic prescription
OBJECTIVES To describe a case of neuroleptic malignant syndrome following antipsychotic treatment of catatonia, highlighting the potentially serious complications of this rare adverse drug reaction. METHODS We present a case report of a patient who developed this syndrome with various sequelae. RESULTS The patient developed neuroleptic after being treated with lorazepam and olanzapine for c...
متن کاملBuffered lidocaine hydrochloride solution with and without epinephrine: stability in polypropylene syringes.
BACKGROUND Pain associated with infiltrating the skin with lidocaine can be reduced by buffering the solution with sodium bicarbonate. OBJECTIVES To determine the physical compatibility and chemical stability of lidocaine hydrochloride solution buffered with 8.4% sodium bicarbonate, with and without epinephrine, packaged in polypropylene syringes and stored at 5°C with protection from light. ...
متن کاملCompatibility of intravenous ibuprofen with lipids and parenteral nutrition, for use as a continuous infusion
There is increasing interest to administer ibuprofen as a continuous infusion instead of a traditional bolus for treating Patent Ductus Arteriosus (PDA). However, its compatibility data with commonly used drugs in the neonatal period, including parenteral nutrition (PN) and lipids is unavailable. The aim is to determine the compatibility of intravenous ibuprofen lysine with various ANZNN parent...
متن کاملInvestigating the Effect of Various Oxidizing Agents on the Surface Functionalization of Microporous Polypropylene Membranes
متن کامل
Neuroleptic malignant syndrome induced by atypical neuroleptics and responsive to lorazepam
OBJECTIVE The authors report three cases of neuroleptic malignant syndrome (NMS) induced by atypical antipsychotics (olanzapine and clozapine) which showed classic features of NMS including muscular rigidity and prominent fever. METHOD Case reports. RESULTS A 66-year-old man with dementia and alcohol abuse developed NMS while on olanzapine for agitation and combativeness. A 62-year-old man ...
متن کامل